Cellular (T cell) immunity against SARS-CoV-2 is likely to be present within most adults six months after primary infection, a new pre-print on bioRxiv suggests.

Preclinical data published in Cell show the nanoparticle vaccine spurs extremely high levels of protective antibodies in animal models. An innovative nanoparticle vaccine candidate for the pandemic coronavirus produces virus-neutralizing antibodies in mice…

Modern western medicine as good as it is is sometimes not what we're looking for. The side effects of some modern drugs can be enough to put you off using them. And in any case,

At a laboratory in Manhattan, researchers have discovered how SARS-CoV-2 uses our defenses against us.

[Updated 27 Sept] Oral calcifediol reduced ICU admission for Covid-19 from 50% to 2%. And key questions about the trial answered.